The Association between Risk Factors and Prodromal Myocardial Infarction Symptoms: A Cross-Sectional Study in Iran by Soltani, Lida et al.
              The Association between Risk Factors…                                                            Lida S. et al.                                                                                           
 
 





The Association between Risk Factors and Prodromal Myocardial 
Infarction Symptoms: A Cross-Sectional Study in Iran 
 
Lida Soltani1, Sakine Sabzevari1*, Ali Ravari2, Tayebeh Mirzaei2, Behnaz 
Bagherian1 
 
OPEN ACCESS  
 
Citation Lida Soltani, Sakine Sabzevari, 
Ali Ravari, Tayebeh Mirzaei, Behnaz 
Bagherian. The Association between Risk 
Factors and Prodromal Myocardial 
Infarction Symptoms: A Cross-Sectional 
Study in Iran. Ethiop J Health 
Sci.2017;29(4):439.doi:http: //dx.doi.org/ 
10.4314/ejhs.v29i4.4  
Received: May 3, 2019 
Accepted: June 3, 2019 
Published: July 1, 2019  
Copyright: © 2019 Lida S., et al . This is 
an open access article distributed under 
the terms of the Creative Commons 
Attribution License, which permits 
unrestricted use, distribution, and 
reproduction in any medium, provided the 
original author and source are credited.  
Funding: Nil  
Competing Interests: The authors 
declare that this manuscript was approved 
by all authors in its form and that no 
competing interest exists.  
Affiliation and Correspondence: 
1Nursing PhD Student.Nursing 
Research Center, Razi School of 
Nursing and Midwifery, Kerman 
University of Medical Sciences, 
Kerman, Iran  
2Department of Medical Surgical 
Nursing, School of Nursing and 
Midwifery, Geriatric Care 
Research Center, Rafsanjan 
University of Medical Sciences, 
Rafsanjan, Iran  













BACKGROUND: Prodromal symptoms in individuals with risk 
factors remain challenging, even though myocardial infarction has 
been noted in research. This study determined the association of 
risk factors with patients’ baseline myocardial infarction related 
prodromal symptoms. 
METHODS: In a cross-sectional study, 154 Iranian men and 
women, mean age 59.62 ± 12.74 years were assessed in 2016–2017. 
The frequency besides severity of 33 prodromal symptoms and risk 
factors was assessed using McSweeney Prodromal Myocardial 
Infarction Symptom Survey .  
RESULTS: The main cardiac prodromal symptoms experienced by 
patients were chest pain/discomfort (n = 99, 64.30%), unusual 
fatigue (n = 78, 50.60%), and sleep disturbance (n = 33, 20.40%). 
Women experienced more prodromal symptoms than men (33.26 ± 
21.88 vs. 25.48 ± 17.75).  Among risk factors, only sex was 
associated with prodromal symptoms score (P < 0.05). 
CONCLUSION: The frequently experienced prodromal symptoms, 
i.e., before MI were chest pain/discomfort, unusual fatigue, and 
sleep disturbance. A crucial finding was the significant association 
between sex and prodromal symptoms. Identifying prodromal 
symptoms in patients with risk factors can prevent the incidence of 
myocardial infarction.  
KEYWORDS: Myocardial Infarction, Prodromal Symptoms, Risk 




Coronary Heart Disease (CHD) kill more than 80% of the people, in 
developing countries (1). In Iran, CHD prevalence will increase over 
2005–2025  and mortality rate accounts for one-fifth of all deaths (2, 
3). More than 90% of the persons in Kerman (city in the southeast of 
Iran) had at least one CHD risk factor (4). According to the results of 
some studies in the US, Spain, Canada, and Iran 49-95% of the 
patients experienced prodromal symptoms (PSs) before the onset of 
myocardial infarction (MI) (5-8). In a study by McSweeney et al. 
(2014), the PSs were the predictors of acute MI in women (9). Also, 
in another study, women, and men who had prodromal chest pain 
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had greater possible risks of chest pain in the acute 
stage of MI (10). These symptoms are subjective, 
variable, and transient which may include cardiac 
and systemic symptoms. Varying in intensity and 
frequent repetitions, PS sometimes last for hours, 
days and even months before MI, and disappear 
later (10-14). In a study in Iran during 2006-2007, 
37% of patients with AMI reported cardiac PS and 
26% systemic PS. The most common cardiac PS 
two weeks before AMI was chest pain (24.2%), 
and the most common systemic PS was loss of 
appetite (12.7%) (8). Another study in 2016 
reported the most common PS were chest pain 
(68%) and epigastric pain (40%) (7). A systematic 
review reported chest discomfort/pain (n = 4, 
57%), arm pain/discomfort (n = 6, 86%), jaw pain 
(n = 3, 43%), back/shoulder blade pain (n = 3, 
43%), unusual fatigue (n = 7, 100%), shortness of 
breath (n = 6, 86%), sleep disturbance(n = 2, 
29%), dizziness (n = 3, 43%), headache (n = 3, 
43%), anxiety (n = 7, 100%), and  gastrointestinal 
complaints (nausea, vomiting, indigestion; n = 5, 
71%)(5) related to PS before MI. 
In spite of the progress in treatment for MI 
and upgraded public awareness of the benefits, 
many people fail to diagnose the PS prior to 
cardiac event, subsequently leading to increased 
prehospital delay and incidence of survival of 
patients with complications such as heart failure 
(13,15,16). Therefore, PS attentiveness is a vital 
precursor to quick interventions that can either 
prevent or delay the progression of CHD with the 
establishment of rapid lifesaving reperfusion 
therapies (17-19).  
Different variables may influence the 
presentation and interpretation of PS among 
patients. In a study, patients with prodromal chest 
pain (PCP) had a higher number of risk factors 
compared with individuals with no PCP (20). 
Previous studies in Canada, the USA, and Norway 
reported that sex, hypertension (HTN) (10,21), 
hyperlipidemia (HLP) (12), diabetes mellitus 
(DM) (8,10), Body Mass Index (BMI)>29 (8,9), 
smoking (8), and family history (FH) of CHD (8) 
were associated with PS. In contrast, some other 
studies in Canada, the USA, Norway indicated 
that HTN(10), HLP(21) DM, BMI>29, smoking, 
FH of CHD were not associated with PS (22). 
Therefore, the association between risk factors and 
PS are unknown yet.  
Increasing mortality from CHD in developing 
countries illustrates the need for identifying at-risk 
groups and areas for probable improvement (23). 
Particular attention to PS in people with risk 
factors is critical for all clinicians and nurses. 
Understanding individual symptoms according to 
risk factors provides critical diagnostic data. Also, 
the precise knowledge of the health providers 
helps warn people who may be at risk and 
accurately diagnose the process. Information about 
PS in high-risk people, such as those with HTN, 
DM, and HLP, is, however, incomplete. This 
study aimed to describe the prevalence and 
frequency of PS and risk factors in a sample of MI 
patients. In particular, we examined the 
association of prodromal symptoms with risk 
factors. 
 
MATERIALS AND METHODS  
 
Design and participants: This study had a cross-
sectional design that was conducted in three 
Cardiac Care Units (CCU) of educational hospitals 
of KermanUniversity of Medical Sciences, in 
Kerman, the Mainmedical Center in Southern Iran. 
All patients with MI who were hospitalized in the 
study settings from 2016 to 2017 were assessed 
for being eligible to participate in the study. 
Patients were eligible if they were able to 
communicate verbally, had PS during the recent 
three months, and had at least one risk factor. 
There were no age restrictions. If patients had a 
non-cardiovascular comorbid condition like 
cancer, were unable to give verbal and written 
informed consent, they were excluded from the 
study. Therefore, 539 hospitalized patients with 
the MI diagnosis were screened for their eligibility 
to participate in study using a convenience 
method. Two hundred and forty-three of them 
were Non-ST Elevation MI (NSTEMI), 57 of 
them were without the cardiac risk factor, 74 
patients did not had any PS during the recent three 
months, and 11 were not interested in participating 
in the study. Finally, 154 patients with ST-
Elevation MI (STEMI) eligibled the study. The 
response rate was 93.33%.  
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McSweeney Prodromal Myocardial Infarction 
Symptom Survey (MPMISS): We used the 
MPMISS includes 33 categorized PS. 
Discomfort/pain throughout chest, centered high 
in the chest, left breast, neck/throat, jaw/teeth, 
back, between/under shoulder blades, top of 
shoulders, and arm(s)/ leg(s). We combined chest 
locations (center or high in the chest, and left 
breast). General symptoms were very 
tired/unusual fatigue, sleep disturbance, and 
anxiety. Heart and lung symptoms were cough, 
heart racing, shortness of breath, and difficulty 
breathing during the night. Gastrointestinal 
symptoms were loss of appetite, and frequent 
indigestion. Sensation in arms symptoms was 
weak/heavy, ache, tingling, numbness or burning 
hands/fingers. Neurological symptoms were new 
onset of vision problem, increased intensity of 
headaches, increase in the frequency of headaches, 
and change in thinking or remembering (24). For 
the PS score, each of the 33 symptoms was 
weighted according to its reported severity (on a 
scale of 1 to 3) and frequency (on a scale of 1 to 6, 
less than monthly = 1 to daily = 6), and was 
summed across symptoms (range: 1-594). The 
MPMISS also contains risk factors BMI>29, DM, 
HTN, HLP, smoking, F.H of CHD, BMI and 
demographics. The presence of DM, HTN, and 
HLP were based on self-report and medical 
records, or the use of medications for these 
disorders. Nicotine addiction was defined as being 
a smoker at the time of the MI based on self-
report.  
Content validity of the MAPMISS was 
evaluated during the development process of the 
instrument by seven content experts. The reliability 
of the MAPMISS as a screening tool was established 
in Caucasian and African American women (test-
retest reliability r = 0.92, P < .001)(24-26). This 
questionnaire has not been used in Iran. Written 
permission was attained from Mc Sweeney for the 
MAPMISS translation. The MAPMISS was 
translated into Persian by using standard protocols 
(33). Two bilingual health professionals translated 
the MAPMISS into Persian and then back into 
English, with a high percentage of agreement on the 
back-translation. The Persian versions were pilot-
tested in Kerman with 20 members of the target 
population who had experienced PS. They did not 
add any additional PS. Fifteen faculty members of 
Kerman University of Medical Sciences assessed the 
qualitative and quantitative content validity of the 
MAPMISS. The Content Validity Index (CVI) was 
0.91. The test-retest Pearson Correlation coefficient 
for 20 patients with two-week interval was 0.76 (P-
value <0.001). Therefore, the validity and reliability 
of the translated questionnaire were acceptable. 
Data Collection: On the third day of admission, we 
conducted bed-side interviews with MI patients in 
the CCU, when they had a stable conditions. The 
baseline interview included questions about PS, 
CHD risk factors, and socio-demographics. The 
researcher asked about the occurrence of each of the 
33 PS in the preceding 90 days. For every one of the 
symptoms reported, we then asked about the 
intensity and frequency with which it occurred. 
Baseline interviews took approximately 30 minutes 
to complete. 
Data analyses: The SPSS-22 statistical software was 
used to analyze the data. The level of significance 
was considered 0.05. The frequency, percentage, 
95% confidence interval, meanand standard 
deviation, independent sample t-test or one-way 
Analyses of Variance (ANOVA), and Pearson 
Correlation were used. Variables that had P-
value<0.25(sex and DM) were entered into 
multivariate linear regression. All probability values 
were 2-tailed. As the only predictor of PS score was 
sex, the frequency of different PSs and risk factors 
were compared between men and women using 
thechi-square test or Fisher's Exact Test.  
Ethical considerations: The Ethical Committee of 
Kerman University of Medical Sciences approved 
the protocol of the study (IR.kmu.REC.13950924). 
The inquiry follows the principles outlined in the 
Statement of Helsinki. The project was explained to 
the patients, and when the patients agreed to 





The mean age of the participants was 59.62 ± 12.74 
years (men: M = 57.35, SD = 12.02; women: M = 
66.55, SD = 12.53). On the other hand, 75.3% of the 
participants were men, and 85.70% were married. 
Then, 32.50% of the samples were illiterate. The 
monthly income of 63.60% of the participants was (75-
225 U.S Dollar). The majority of the participants were 
self-employed (33.10%) and resident of the city 
(90.77%)(Table 1). 
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Table 1: Socio-demographic characteristics of patient sample (n=154) and their associations with the PS score.  
 




Age (yr.) Mean (SD) 59.62 (12.74) 27.40(19.07) r= 0.18 0.83 
     
 
Marital status 
Married 132 (85.70) 26.26 (18.17) t=-1.99 0.08 
Living alone* 22 (14.30) 35.10 (23.90) 
Education Illiterate 50 (32.50) 28.84 (19.20) F=1.66 0.18 
Primary 55 (35.70) 30.32 (22.09) 
Secondary 30 (19.50) 23.83 (15.88) 




<75 20 (13.00) 27.20 (19.45) F 
=0.93 
0.40 
75 – 225 98 (63.60) 26.07 (20.53) 
> 225 36 (23.40) 31.14 (14.06) 
Job Self-
employed 
51 (33.10) 26.65 (19.31) F 
=0.22 
0.88 
Employee 28 (18.20) 26.79 (19.70) 
Retired 42 (27.30) 26.83 (20.88) 
Housewife 33 (21.40) 29.82 (16.24) 
Location city 120 (90.77) 27.47 (19.87) F=0.08 0.94 
Village 34 (10.22) 27.18(16.24) 
*Unmarried/divorced/widowed, r = Pearson correlation coefficient, t= Independent t-test, F = ANOVA 
 
Most participants experienced pain or discomfort 
(94.2%; CI: 90.2-97.5%), and the most pain or 
discomfort reported by them was any chest 
pain/discomfort (n=99, 64.30%) (Table 2). Also, very 
tired/unusual fatigue (n=78, 50.60%), and sleep 
disturbance (n=33, 20.40) were the frequently 
experienced symptoms among general symptoms. The 
range of PS score was 4-114 (mean±SD 27.40±19.07), 
and the participants experienced between 1 to 10 
symptoms. The of PS score in men and women was 
(mean ±SD) 3.56 ± 2.11vs. 2.95 ± 1.81. 
The most common risk factors were HTN 
(44.2%), HLP (31.2%) and DM (31.2%), respectively. 
All participants had at least two and at most six risk 
factors. Among all risk factors, women reported 
significantly higher levels of PS score than men (P < 
0.05) (Table 3). However, among all symptoms, 
women had more pain/discomfort than men, but it was 
not statistically significant (Table 2).  
 




Overall Men (Frequency/%) Women 
(Frequency/%) 
P-
value Frequency Percent (CI) 
Pain or discomfort 145 94.2 (90.2-97.5) 107 (92.2) 38 (100) 0.11 
General symptoms 96 62.3 (55.7-73.4) 71 (62.9) 25 (60) 0.80 
Heart and lung 47 27.8 (24-39) 40 (34.5) 7(18.4) 0.06 
Gastrointestinal 33 22.6 (14.3-27.9) 27 (23.3) 6 (15.8) 0.33 
Sensation in arms 37 24 (16.9-31.2) 28 (24.1) 9 (23.7) 0.95 
Neurological 
symptoms 
27 15.7 (11.6-24) 21 (18.1) 6 (15.8) 0.74 
Number of PS 
1 26 16.9 (11 – 22.2) 20 (17.2) 6 (15.8) 0.41 
2 42 27.3 (20.1 – 33.8) 29 (25) 13 (34.2) 
3 31 20.1 (13.6 – 26.6) 21 (18.1) 10 (26.3) 
4 17 11 (7.1 – 16.9) 13 (11.2) 4 (10.5) 
5 16 10.4 (5.8 – 15.7) 13 (11.2) 3 (7.9) 
≥6 22 14.3 (9.1 – 20.9) 20 (17.2) 2 (5.3) 
CI = Confidence Interval, PS = Prodromal symptoms, *Fisher's Exact Test 
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Table 3: The prevalence of risk factors and their associations with the PS score 
 





Sex Male 116 (75.3) 25.48 (17.75) -
2.21 
0.03 
Female 38 (24.7) 33.26 (21.88) 
BMI >29 19 (12.3) 26.80 (24.35) -
0.14 
0.88 
<29 135 (87.7) 27.50 (18.33) 
Smoke Yes 45 (29.2) 26.15 (15.15) -
0.52 
0.60 
No 109 (70.8) 27.91 (20.52) 
DM Yes 48 (31.2) 30.06 (21.28) 1.16 0.25 
No 106 (68.8) 26.19 (17.97) 
F.H of 
 CHD 
Yes 45 (29.2) 29.56 (20.15) 0.84 0.40 
No 109 (70.8) 26.62 (18.70) 
HTN Yes 68 (44.2) 28.59 (20.61) 0.68 0.51 
No 86 (55.8) 26.47 (17.84) 
HLP Yes 48 (31.2) 29.98 (22.00) 1.12 0.26 
No 106 (68.8) 26.24 (17.56) 
BMI =Body Mass Index, DM = Diabetes Mellitus, F.H of CHD = Family History of Coronary Heart Disease, HTN = Hypertension, 
HLP = Hyperlipidemia 
 
All risk factors that had a P-value of less than 0.25 in 
bivariate analysis, i.e., sex and DM, were entered into 
multivariate linear regression with the backward 
method. The results indicated that only sex was a 
significant predictor of the PS score; it explained 2.5% 
of the variance (B = 7.78, CI = 0.82 – 14.74, P = 0.03; 
R2=.026, P = .046). 
The prevalence of being a smoker was significantly 
higher in men than women (P < 0.05). Also, positive 
history of HTN was significantly higher in women than 
in men (P < 0.05). No differences regarding other risk 
factors were observed between women and men (Table 
4). The range of risk factors was 2-6 and men (mean ± 
SD, 3.41±0.94) vs. women (mean ± SD, 3.61±0.94). 
 
Table 4: The comparisons of risk factors between men and women 
 




Chi-square test            P-value* 
BMI>29 14 (12.2) 5 (12.8) 0.01 0.91 
Smoke 40 (34.8) 5 (12.8) 6.80 0.009 
DM 32 (27.8) 16 (41) 2.36 0.12 
F.H of CHD 29 (25.2) 12 (30.8) 0.46 0.50 
HTN 40 (34.8) 28 (71.8) 16.18 <0.001 
HLP 35 (30.4) 13 (33.3) 0.11 0.74 
Number of  
riskfactors 
    
2 16 (13.8) 3 (7.9) 1.61 0.81 
3 54 (46.6) 17 (44.7) 
4 31 (26.7) 11 (28.9) 
5 12 (10.3) 6 (15.8) 
6 3 (2.6) 1 (2.6) 
BMI =Body Mass Index, DM = Diabetes Mellitus, F.H of CHD = Family History of Coronary Heart Disease, HTN = Hypertension, 
HLP = Hyperlipidemia 
 
DISCUSSION 
Our result showed that the majority of the participants 
experienced pain or discomfort (94%), especially chest 
pain/discomfort (64.30%). Also, among general 
symptoms, the participants experienced very 
tired/unusual fatigue (50.60%) and sleep disturbance 
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(20.40%) more than other symptoms. The mean score 
of PS was 27.40 (range = 4-114). Only sex was a 
predictor of the PS score, i.e. women reported higher 
levels of PS score than men. Also, the prevalence of 
being a smoker was higher in men than inwomen while 
a positive history of HTN was higher in women than 
men.   
In this investigation, the most frequently reported 
PSs were chest pain (64.30%), unusual fatigue 
(50.60%), and sleep disturbance (20.40%). In line with 
our results, O’Keefe-McCarthy et al. in a study on 121 
patients diagnosed with ACS in one emergency 
department in Canada, reported that the most frequent 
PSs were chest pain (70%), and unusual fatigue 
(53%)(15). The most frequent PS, in patients with first 
AMI reported by Hwang et al. in Korea was pain-
related symptoms such as chest, epigastria, or back pain 
(38.6%)(13). Khan et al. stated that the most common 
PSs in men and womenin Canada, USA, and 
Switzerland were unusual fatigue (47.2%), and sleep 
disturbances (41%), but chest painw as approximately 
24% (22). In the United States, McSweeney et al., 
found in a multi-center, retrospective telephone survey 
of an ethnically diverse group of women who had 
experienced an AMI (n=1270) that unusual fatigue 
(73%), and sleep disturbance (50%) were the most 
frequent PS,; nevertheless, chest discomfort or pain 
prevalence was 36% (27). Another research in the US 
on 515 women diagnosed with AMI was done by 
McSweeney et al. The most frequent PSs during the 
recent month to AMI were unusual fatigue (70.7%), 
sleep disturbance (47.8%), and shortness of breath 
(42.1%). However, chest discomfort incidence was 
29.7% (6). The ethnic dissimilarities of symptom 
presentation are known; however, chest pain is a crucial 
symptom regularly experienced by patients with heart 
disease (11,28,29). People with prodromal pain or 
discomfort, shortness of breath, fatigue, sleep 
disturbance, and anxiety were more likely to have 
similar symptoms through the acute phase of an ACS 
(6,9,10,30-32). Also, in a study, women, and men who 
had prodromal chest pain had more than five and three 
times greater possible risks of chest pain in the acute 
stage of MI than those who did not have PS, 
respectively (10). In another study by McSweeney et al. 
(2014), discomfort in jaws/teeth, unusual fatigue, arm 
discomfort, shortness of breath, and generalized chest 
discomfort were the predictors of acute cardiac events 
in women (9). Therefore, according to the previous 
studies and this study, pain/discomfort, unusual fatigue, 
sleep disturbance, shortness of breath, are the 
frequently experienced PSs before AMI.  
This study showed that the mean score of PS was 
27.40 (Minimum = 4, and Maximum = 114). In contrast 
with our result, in two studies on women, the PS score 
was 55 to 80 (6,11). The majority of our participants 
were men while in McSweeney et al.’s studies, only 
women were assessed. Therefore, the lower level of PS 
score in this study, in comparison with the previous 
studies (9), may be due to the characteristics of the 
studied sample. 
In this study, only sex was a predictor of PS 
score,i.e. women reported higher levels of PS score 
than men. In line with our results, in a study by 
Lovlienet al., 84% of the women and 76% of the men 
had PS, and these symptoms were found to predict 
symptoms that occurred in the acute phase of MI(10). 
Holfgren et al., stated in a sample of Swedish ACS 
patients (n=914) that women experienced more PS than 
men (70% vs. 58%) (32). In a cross-sectional study of 
1145 ACS patients ≤55 years, who experienced at least 
one PS, women compared to men, were more likely PS 
(85% vs. 72%) (22). Graham et al., in a study on 
patients with ACS in Canada, revealed a significant 
interaction between sex and PS (12). Contrastingly, the 
results of a descriptive study in Korea by Hwang et al. 
demonstrated that 53% of male patients and 54% of 
female patients had PS; no significant sex-based 
differences were discerned (13). Also, Løvlien et al., in 
their study on Norwegian patients with first time AMI 
(n=533) and O’Keefe-McCarthy et al. in a survey on 
121 Canadian patients diagnosed with ACS reported 
that there were not differences between men and 
women regarding PS (10,15). The conflict in the 
consequences might be due to each study's participants' 
characteristics, the cultural background, personal and 
families’ or friends’ disease experiences. However, the 
reasons for sex variances in PS presentation are not 
well-known. The anatomical, physiological, biological 
and psychosocial diversity between men and women 
may influence the PS presentation(33). The history of 
different risk factors such as obesity, DM, HTN, HLP, 
and smoking may affect the presentation of the 
symptoms. In this study, the higher prevalence of being 
smoker in men than in women and positive history of 
HTN in women than men can be reasons for these 
differences.  
However, the prevalence of HTN and smoking in 
a study in the United States and Spain were not 
different between women and men (34). In a review 
research in 2015, it was confirmed that the global 
prevalence of smoking in men was 48%, nearly five 
times as high as it was in women (10%), while the 
prevalence of HTN was parallel in men and women 
(35). Also, in contrast with our results, in some other 
studies, women with PS had a higher probability of 
having a FH of CHD(22, 36). Therefore, the essential 
causes for gender differences in experiencing PS are 
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uncertain. Note, we could not find any other similar 
studies in Iran about the association between PS and 
gender. More investigation is therefore necessary on 
this issue in the Iranian context.  
In this study, none of the six measured risk 
factors, i.e., HTN, HLP, DM,BMI>29, smoking, and 
FH of CHD were a significant predictor of PS score. 
Our results supported results of some previous studies 
in Canada, USA, and Norway which indicated that 
HTN, HLP (10), DM, BMI>29, smoking, and FH of 
CHD were not associated with PS (22). However, our 
results are in contrast with results of some previous 
studies. On the other hand, some of theresults of 
previous studies showed that HTN (10,14), HLP, DM 
(8,10), BMI>29 (8,9), smoking (8), FH of CHD (8) 
were associated with PS. The differences among the 
studies confirm that the associations between PS and 
risk factors are controversial and need more 
investigation. 
In conclusion, developed recognition and 
emergent treatment of PS would benefit all patients 
who have risk factors. Prodromal chest pain, unusual 
fatigue, and sleep disturbance were the most dominant 
symptoms idendified in this sample. The results further 
suggested that there is an association between sex and 
PS symptoms. These results may be important for the 
development of educational and treatment 
interventions. Additional research is required to 
confirm if PSs with regard to sex, age, and socio-
economic status are a stronger predictor of risk factors-
related PS presentation. Initial recognition of PS may 
help identification of persons at risk for the progress of 
CHD, early CHD detection through PS screening tools 
in clinical practice, and individualized risk factor index 
modification and management. Eventually, information 
of risk factors-related PS may confirm the decline in 
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